BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 24438587)

  • 21. Role of infection in irritable bowel syndrome.
    Spiller RC
    J Gastroenterol; 2007 Jan; 42 Suppl 17():41-7. PubMed ID: 17238025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. To "lump" or to "split" the functional somatic syndromes: can infectious and emotional risk factors differentiate between the onset of chronic fatigue syndrome and irritable bowel syndrome?
    Moss-Morris R; Spence M
    Psychosom Med; 2006; 68(3):463-9. PubMed ID: 16738080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Post-infectious irritable bowel syndrome].
    Serghini M; Karoui S; Boubaker J; Filali A
    Tunis Med; 2012 Mar; 90(3):205-13. PubMed ID: 22481191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microbiota, gastrointestinal infections, low-grade inflammation, and antibiotic therapy in irritable bowel syndrome: an evidence-based review.
    Schmulson M; Bielsa MV; Carmona-Sánchez R; Hernández A; López-Colombo A; López Vidal Y; Peláez-Luna M; Remes-Troche JM; Tamayo JL; Valdovinos MA
    Rev Gastroenterol Mex; 2014; 79(2):96-134. PubMed ID: 24857420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postinfectious irritable bowel syndrome after travelers' diarrhea--a cohort study.
    Schwille-Kiuntke J; Enck P; Polster AV; Gaile M; Kremsner PG; Zanger P
    Neurogastroenterol Motil; 2015 Aug; 27(8):1147-55. PubMed ID: 26009981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The possible role of bacteria, viruses, and parasites in initiation and exacerbation of irritable bowel syndrome.
    Shariati A; Fallah F; Pormohammad A; Taghipour A; Safari H; Chirani AS; Sabour S; Alizadeh-Sani M; Azimi T
    J Cell Physiol; 2019 Jun; 234(6):8550-8569. PubMed ID: 30480810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS.
    Dunlop SP; Jenkins D; Neal KR; Spiller RC
    Gastroenterology; 2003 Dec; 125(6):1651-9. PubMed ID: 14724817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relative importance of abnormalities of CCK and 5-HT (serotonin) in Giardia-induced post-infectious irritable bowel syndrome and functional dyspepsia.
    Dizdar V; Spiller R; Singh G; Hanevik K; Gilja OH; El-Salhy M; Hausken T
    Aliment Pharmacol Ther; 2010 Apr; 31(8):883-91. PubMed ID: 20132151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in the symptom pattern and the densities of large-intestinal endocrine cells following Campylobacter infection in irritable bowel syndrome: a case report.
    El-Salhy M; Mazzawi T; Gundersen D; Hatlebakk JG; Hausken T
    BMC Res Notes; 2013 Sep; 6():391. PubMed ID: 24073715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postinfectious irritable bowel syndrome: a long-term consequence of bacterial gastroenteritis.
    Smith JL; Bayles D
    J Food Prot; 2007 Jul; 70(7):1762-9. PubMed ID: 17685356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Irritable bowel syndrome following Clostridium difficile infection.
    Dayananda P; Wilcox MH
    Curr Opin Gastroenterol; 2019 Jan; 35(1):1-5. PubMed ID: 30335629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Post-infectious irritable bowel syndrome. A review based on current evidence].
    Gómez-Escudero O; Schmulson-Wasserman MJ; Valdovinos-Díaz MA
    Rev Gastroenterol Mex; 2003; 68(1):55-61. PubMed ID: 12940101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Irritable bowel syndrome: a review on the role of intestinal protozoa and the importance of their detection and diagnosis.
    Stark D; van Hal S; Marriott D; Ellis J; Harkness J
    Int J Parasitol; 2007 Jan; 37(1):11-20. PubMed ID: 17070814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Campylobacter jejuni genotypes are associated with post-infection irritable bowel syndrome in humans.
    Peters S; Pascoe B; Wu Z; Bayliss SC; Zeng X; Edwinson A; Veerabadhran-Gurunathan S; Jawahir S; Calland JK; Mourkas E; Patel R; Wiens T; Decuir M; Boxrud D; Smith K; Parker CT; Farrugia G; Zhang Q; Sheppard SK; Grover M
    Commun Biol; 2021 Aug; 4(1):1015. PubMed ID: 34462533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eight year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery.
    Marshall JK; Thabane M; Garg AX; Clark WF; Moayyedi P; Collins SM;
    Gut; 2010 May; 59(5):605-11. PubMed ID: 20427395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome.
    Barbara G; Zecchi L; Barbaro R; Cremon C; Bellacosa L; Marcellini M; De Giorgio R; Corinaldesi R; Stanghellini V
    J Clin Gastroenterol; 2012 Oct; 46 Suppl():S52-5. PubMed ID: 22955358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunization with cytolethal distending toxin B produces autoantibodies to vinculin and small bowel bacterial changes in a rat model of postinfectious irritable bowel syndrome.
    Morales W; Triantafyllou K; Parodi G; Weitsman S; Park SC; Rezaie A; Pichetshote N; Lin E; Pimentel M
    Neurogastroenterol Motil; 2020 Oct; 32(10):e13875. PubMed ID: 32436301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors.
    Lee KJ; Kim YB; Kim JH; Kwon HC; Kim DK; Cho SW
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1689-94. PubMed ID: 19120860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An outbreak of acute bacterial gastroenteritis is associated with an increased incidence of irritable bowel syndrome in children.
    Thabane M; Simunovic M; Akhtar-Danesh N; Garg AX; Clark WF; Collins SM; Salvadori M; Marshall JK
    Am J Gastroenterol; 2010 Apr; 105(4):933-9. PubMed ID: 20179687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics and Risk Factors of Post-Infection Irritable Bowel Syndrome After Campylobacter Enteritis.
    Berumen A; Lennon R; Breen-Lyles M; Griffith J; Patel R; Boxrud D; Decuir M; Farrugia G; Smith K; Grover M
    Clin Gastroenterol Hepatol; 2021 Sep; 19(9):1855-1863.e1. PubMed ID: 32711045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.